interaction records 54 assistance programs 55 0 personal data stored

Generic competition · all medicines · read 12 November 2026

Is there a generic of Cefazolin Sodium, and who makes it?

Cefazolin Sodium appears in 3 dosage-form groups in the FDA Orange Book as of 12 November 2026, with 5 generic makers listed as marketed across them. 2 groups have a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming. Where both are dated, the first generic approval came 2.3 years after the first brand approval. This is the Orange Book's listing, not a forecast.

Compiled and checked by Vincent Wesley Couey (ORCID 0009-0005-6869-308X) from the Orange Book data files, downloaded 12 November 2026.

Not medical advice. This page reports what the FDA's Orange Book lists, not what a pharmacy has in stock, what anything costs, or whether a generic is right for you. Ask your pharmacist or prescriber about your own medicine.
Cefazolin Sodium3 dosage-form groups in the Orange Book
5generic makers listed
  1. Cefazolin Sodium appears in 3 dosage-form groups in the FDA Orange Book as of 12 November 2026, with 5 generic makers listed as marketed across them.
  2. 2 groups have a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming.
  3. Where both are dated, the first generic approval came 2.3 years after the first brand approval.
  4. Patents and exclusivities are shown as listed by the application holder; the Orange Book does not rule on them, and a listed patent is not a statement that a generic is blocked. This says nothing about price, supply or quality.

Injectable, Injection

Four or more generic makers listed

Brand listed as marketed: Cefazolin And Dextrose. 5 generic makers with 16 generic products listed as marketed; the first generic approval is dated 10 September 1985.

1980198519901995200020052010201520202025203005brand 1983Sandoz Inc, first approval 9 December 1988Hikma Farmaceutica Portugal Lda, first approval 18 September 2001Samson Medical Technologies Llc, first approval 29 November 2006Acs Dobfar Spa, first approval 22 October 2008Qilu Antibiotics Pharmaceutical Co Ltd, first approval 28 December 2015data date
generic makers listed as marketed, by first approvallisted patent expiryexclusivity end
Generic maker (applicant)First approvalProducts
Sandoz Inc9 December 19883
Hikma Farmaceutica Portugal Lda18 September 20013
Samson Medical Technologies Llc29 November 20062
Acs Dobfar Spa22 October 20084
Qilu Antibiotics Pharmaceutical Co Ltd28 December 20154

Patents and exclusivities still listed

No unexpired patent or exclusivity is listed against the marketed brand products in this group.

Powder, Intravenous

Brand listed, no generic listed as marketed

Brand listed as marketed: Cefazolin Sodium. No generic is listed as marketed.

20202025203001brand 2022data date
generic makers listed as marketed, by first approvallisted patent expiryexclusivity end

Patents and exclusivities still listed

No unexpired patent or exclusivity is listed against the marketed brand products in this group.

Solution, Intravenous

Brand listed, no generic listed as marketed

Brand listed as marketed: Cefazolin In Dextrose. No generic is listed as marketed.

201520202025203001brand 2015data date
generic makers listed as marketed, by first approvallisted patent expiryexclusivity end

Patents and exclusivities still listed

No unexpired patent or exclusivity is listed against the marketed brand products in this group.

US Food and Drug Administration, Orange Book data files, downloaded 12 November 2026. A listed patent is not a ruling that a generic is blocked, and no figure here says anything about price, supply or quality. Check the Orange Book.

Where can you go from this result?

Open it in the check to search another medicine, or see every brand with no generic listed. The FDA explains generic approval in how generic drugs are approved and the FDA generic drug facts, and the Orange Book itself is the FDA Orange Book. To check what is available now, ask your pharmacist, and see the FDA drug shortages page.